Hi Rlj
Yes - I hope that is indeed the case. It makes a lot more sense to me.
I recently increased my holding of PTX and I will probably buy more at current levels, but I do think they should be paying more attention to what they say and communicating better generally. If they did, I believe the SP could be significantly higher. I'm sure the poor comms from PTX is the reason that the SP actually fell today, despite what should have been an an encouraging Announcement. It's an interesting contrast with the market reaction to Imugene's last two Announcements of dose escalation in their PD1-vaxx. I know many people here hold shares in both companies.
It is long past time that PTX explained exactly what is happening next (if anything) with the PTX-200 trials in Breast Cancer and Ovarian Cancer. On clinical trials.gov the two previous studies are both showing simply as "terminated."
The Ovarian Cancer trial status says:
Recruitment Status : Terminated (Enrollment stopped prior to Phase 1b, change in strategic focus)First Posted : September 21, 2012
Last Update Posted : September 24, 2020
Source:
https://clinicaltrials.gov/ct2/show/NCT01690468?term=PTX-200&draw=2&rank=2The Breast Cancer trial status says: Recruitment Status : Terminated (criteria for continuing enrollment in Phase 2 portion was not met)
First Posted : October 2, 2012Last Update Posted : September 24, 2020
Source:
https://clinicaltrials.gov/ct2/show/NCT01697293?term=PTX-200&draw=2&rank=3The lack of a proper market Announcement is pretty poor. If I have missed something, of course, I'm happy to retract that comment. If I haven't missed something, then I wonder if PTX should be receiving a "please explain" from the ASX.
I'm not trying to down ramp here. I'm still holding and I think PTX is still a "buy" for me. In fact like
@Mr.Gold I think they are still a bargain at these levels, so maybe I should be happy that they are hopeless communicators - their crappy comms will be keeping the SP low and that gives me a chance to accumulate more.
However, I would be much much happier if they did improve their communications.
Anyway - good luck to us all, and especially to all the poor people living with AML, or Breast Cancer, or Ovarian Cancer.... My heart goes out to them and I profoundly wish for success in the various clinical trials PTX has under way or planned.
Cheers
Dave
